Aureomycin description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Aureomycin

Alpharma Inc. Animal Health

Aureomycin 50 Granular A


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

Chlortetracycline
Type A Medicated Article

Active drug ingredient

Chlortetracycline calcium complex equivalent to 50 g chlortetracycline hydrochloride per lb.

Ingredients

Aureomycin Granular Type A Medicated Article (Dried Streptomyces aureofaciens Fermentation Product and Calcium Sulfate) and Calcium Carbonate.

Purpose

For use in the manufacture of medicated animal feeds. For use in dry feed only. Not for use in liquid medicated feeds.

Use directions

Mix sufficient Aureomycin 50 Granular A Medicated Article to supply desired concentration of chlortetracycline per ton with part of the feed ingredients to make a preblend. Add the remainder of the ingredients and mix thoroughly. For specific use levels, see Indications .

Mixing directions

Level desired
grams per ton
Amount of medicated article per tonIt is recommended that 1 pound of Aureomycin 50 Granular A Type A Medicated Article be diluted with 4 pounds of one of the feed ingredients to form a 5 pound working premix. Use 1 pound of the working premix to make a preblend (see Use directions ) for a Type C feed containing 10 g Aureomycin chlortetracycline / ton of feed.
10 1/5 lb
50 1 lb
100 2 lb
200 4 lb
400 8 lb
500 10 lb
Indications Chlortetracycline
mg per lb body
wt per day
Cattle
Calves (up to 250 lb): Increased rate of weight gain and improved feed efficiency. 0.1
   
Beef Cattle (over 700 lb): Control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline. 0.5
   
Beef and Non-Lactating Dairy Cattle: As an aid in the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline when delivered in a free-choice feed. Free-choice feed must be manufactured under a feed mill license utilizing an FDA approved formulation. 0.5 - 2.0
   
Calves, Beef and Non-Lactating Dairy Cattle:
Treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. Feed for not more than 5 days. The appropriate amount of Aureomycin-containing feed supplement may be mixed in the cattle's daily ration or administered as a top-dress. If the Aureomycin-containing feed supplement is administered as a top-dress, it must be spread uniformly on top of the ration and sufficient space must be provided so that all cattle can eat at the same time. 10
Swine
Control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis susceptible to chlortetracycline. Treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline. (Note: this drug level is equivalent to approximately 400 grams per ton, depending on feed consumption and body weight.) Feed for not more than 14 days. 10
Indications In complete feed
Chlortetracycline
g per ton
Swine
Increased rate of weight gain and improved feed efficiency. 10 - 50
   
Reduction in the incidence of cervical lymphadenitis (jowl abscesses) caused by Group E Streptococci susceptible to chlortetracycline. 50 - 100
   
Breeding Swine: Control of leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to chlortetracycline.
Feed continuously for not more than 14 days.
400
Indications mg per head
per day
Cattle
Calves (250 to 400 lb): Increased rate of weight gain and improved feed efficiency. 25 - 70
   
Growing Cattle (over 400 lb): Increased rate of weight gain, improved feed efficiency, and reduction of liver condemnation due to liver abscesses. 70
   
Beef Cattle: Control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline. 350
   
Beef Cattle (under 700 lb): Control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline. 350

Warning

A withdrawal period has not been established for this product in pre-ruminating calves.
Do not use in calves to be processed for veal.
Do no feed to ducks or turkeys producing eggs for human consumption.

NADA 48-761, Approved by FDA

Marketed by
Alpharma Inc.
Bridgewater, New Jersey 08807

Net wt 10 LB (4.54 kg)

Aureomycin

Trademarks
registered by
Alpharma Inc.

700617 0812

PRINCIPAL DISPLAY PANEL - 10 LB Bag

Aureomycin®
50 Granular A

ALPHARMA

GUARANTEED
AUREOMYCIN®
CHLORTETRACYCLINE

Chlortetracycline
Type A Medicated Article

Net wt 10 LB (4.54 kg)

Aureomycin

Aureomycin

Chlortetracycline Hydrochloride GRANULE

Product Information

Product Type Otc type a medicated article animal drug label Item Code (Source) NDC:46573-002
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
Chlortetracycline Hydrochloride CHLORTETRACYCLINE 50 g

Inactive Ingredients

Ingredient Name Strength
CALCIUM CARBONATE
CALCIUM SULFATE

Product Characteristics

Color
GRAY (gray to brown)

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:46573-002-21 4.5 in 1 BAG

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NADA NADA048761 2009-01-01


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.